0001279569-19-000811.txt : 20190403 0001279569-19-000811.hdr.sgml : 20190403 20190403124337 ACCESSION NUMBER: 0001279569-19-000811 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20190403 FILED AS OF DATE: 20190403 DATE AS OF CHANGE: 20190403 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Correvio Pharma Corp. CENTRAL INDEX KEY: 0001036141 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29338 FILM NUMBER: 19728120 BUSINESS ADDRESS: STREET 1: 6TH FLOOR STREET 2: 1441 CREEKSIDE DRIVE CITY: VANCOUVER STATE: A1 ZIP: V6J 4S7 BUSINESS PHONE: 1-604-677-6905 MAIL ADDRESS: STREET 1: 6TH FLOOR STREET 2: 1441 CREEKSIDE DRIVE CITY: VANCOUVER STATE: A1 ZIP: V6J 4S7 FORMER COMPANY: FORMER CONFORMED NAME: Cardiome Pharma Corp DATE OF NAME CHANGE: 20040625 FORMER COMPANY: FORMER CONFORMED NAME: CARDIOME PHARMA CORP DATE OF NAME CHANGE: 20000407 6-K 1 correvio6k.htm FORM 6-K

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13A-16 or 15d-16 of

The Securities Exchange Act of 1934

 

For the month of April 2019

 

COMMISSION FILE Number. 000-29338

 

CORREVIO PHARMA CORP.

 

(Translation of registrant’s name into English)

 

1441 Creekside Drive, 6th floor

Vancouver, British Columbia, V6J 4S7, CANADA

 

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F

 

Form 20-F ☐ Form 40-F ☒

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

  

 

 

 
 

 

 

DOCUMENTS INCLUDED AS PART OF THIS REPORT

 

Exhibit   Description
     
99.1   News Release dated April 3, 2019

  

 

 

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  CORREVIO PHARMA CORP.
  (Registrant)
     
Date: April 3, 2019 By: /s/ Justin Renz
    Name: Justin Renz
    Title: President and Chief Financial Officer

 

 

 


 EX-99.1 2 ex991.htm NEWS RELEASE DATED APRIL 3, 2019

Exhibit 99.1

 

 

Correvio Announces Zevtera® Abstracts at ECCMID 2019

NASDAQ: CORV   TSX: CORV

Seven Data Abstracts Selected for Poster Presentations  

VANCOUVER, April 3, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that seven abstracts featuring Zevtera/Mabelio (ceftobiprole medocaril sodium), an intravenous (IV) cephalosporin antibiotic with rapid bactericidal activity against a wide range of Gram-positive and Gram-negative bacteria, were selected for presentation at the 29th European Congress of Clinical Microbiology and Infectious Disease (ECCMID), being held April 13-16, 2019 in Amsterdam, the Netherlands.  Correvio currently markets ceftobiprole under the brand name Mabelio in Italy and France and under the brand name Zevtera in the UK, Germany, Spain, Austria and Switzerland. 

"Zevtera/Mabelio addresses a major medical need for antibiotics against resistant bacterial pathogens in patients with hospital- and community-acquired pneumonia," said Carin Heringa, Correvio's Head of Medical Affairs. "The Zevtera/Mabelio data being presented at ECCMID this year continue to demonstrate its potent activity against critical Gram-positive and Gram-negative bacteria, including multidrug-resistant pathogens that cause some of the most serious and life-threatening infections." 

Details for the Zevtera/Mabelio poster presentations at ECCMID are as follows:

Title: In vitro activity of ceftobiprole against Gram-positive isolates from clinical samples from a tertiary hospital 
Lead author: Francisco Javier Candel
Date and time: Monday, 15 April 2019; 13:30 – 14:30 CET
Location: Paper Poster Arena
Poster number: #P1863
Session info: PS107 – In vitro activity of newer antibacterial agents

Title: In vitro activity of ceftobiprole against isolates of common involved pathogens in nosocomial pneumonia from a tertiary hospital 
Lead author: Francisco Javier Candel
Date and time: Monday, 15 April 2019; 13:30 – 14:30 CET
Location: Paper Poster Arena
Poster number: #P1864
Session info: PS107 – In vitro activity of newer antibacterial agents

Title: Susceptibility of ceftobiprole and other beta-lactams against Gram-negative pathogens from hospital-acquired pneumonia in the UK and Ireland since 2011 
Lead author: Beate Ritz
Date and time: Monday, 15 April 2019; 13:30 – 14:30 CET
Location: Paper Poster Arena
Poster number: #P1865
Session info: PS107 – In vitro activity of newer antibacterial agents

Title: Susceptibility of ceftobiprole and comparators against methicillin-resistant Staphylococcus aureus from respiratory tract infections 
Lead author: Stephen Hawser
Date and time: Monday, 15 April 2019; 13:30 – 14:30 CET
Location: Paper Poster Arena
Poster number: #P1866
Session info: PS107 – In vitro activity of newer antibacterial agents

Title: Activity of ceftaroline and ceftobiprole against staphylococci and Streptococcus pneumoniae in the UK and Ireland 
Lead author: Carolyn Horner
Date and time: Monday, 15 April 2019; 13:30 – 14:30 CET
Location: Paper Poster Arena
Poster number: #P1867
Session info: PS107 – In vitro activity of newer antibacterial agents

Title: 18 months of real-life use of ceftobiprole: clinical experience in an internal medicine ward 
Lead author: Giuseppe Russo
Date and time: Monday, 15 April 2019; 13:30 – 14:30 CET
Location: Paper Poster Arena
Poster number: #P1911
Session info: PS110 – Clinical efficacy studies for antimicrobial agents

Title: PBP2a mutations do not affect bactericidal activity to ceftaroline and ceftobiprole in clinical MDR-MRSA isolates 
Lead author: Floriana Campanile
Date and time: Tuesday, 16 April 2019; 12:30 – 13:30 CET
Location: Paper Poster Arena
Poster number: #P2849
Session info: PS161 – Resistance mechanisms in Gram-positive cocci

About Zevtera® / Mabelio® (ceftobiprole)

Zevtera® (ceftobiprole medocaril sodium) is a cephalosporin antibiotic for intravenous administration with rapid bactericidal activity against a wide range of Gram-positive and Gram-negative bacteria, including methicillin-susceptible and resistant Staphylococcus aureus (MSSA, MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA), coagulase-negative staphylococci (CoNS), Enterococcus faecalis, and susceptible Pseudomonas spp. Ceftobiprole is currently approved for sale in 16 European countries and several non-European countries for the treatment of adult patients with community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP), excluding ventilator-associated pneumonia (VAP). Ceftobiprole is currently commercialized by Correvio in Italy, France, Germany, the U.K., Austria, Spain and Switzerland under the brand name Zevtera® or Mabelio®.

About Correvio Pharma Corp.

Correvio Pharma Corp. is a specialty pharmaceutical company focused on providing innovative, high-quality brands that meet the needs of acute care physicians and patients. With a commercial presence and distribution network covering over 60 countries worldwide, Correvio develops, acquires and commercializes brands for the in-hospital, acute care market segment. The Company's portfolio of approved and marketed brands includes: Xydalba™ (dalbavancin hydrochloride), for the treatment of acute bacterial skin and skin structure infections (ABSSSI); Zevtera®/Mabelio® (ceftobiprole medocaril sodium), a cephalosporin antibiotic for the treatment of community- and hospital-acquired pneumonia (CAP, HAP, excluding ventilator-associated pneumonia, VAP); Brinavess® (vernakalant IV) for the rapid conversion of recent onset atrial fibrillation to sinus rhythm; Aggrastat® (tirofiban hydrochloride) for the reduction of thrombotic cardiovascular events in patients with acute coronary syndrome, and Esmocard® and Esmocard Lyo® (esmolol hydrochloride), a short-acting betablocker used to control rapid heart rate in a number of cardiovascular indications. Correvio's pipeline of product candidates includes Trevyent®, a drug device combination that is designed to deliver treprostinil, the world's leading treatment for pulmonary arterial hypertension.

Correvio is traded on the NASDAQ Capital Market (CORV) and the Toronto Stock Exchange (CORV). For more information, please visit our web site www.correvio.com.

Forward-Looking Statement Disclaimer

Certain statements in this news release contain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 or "forward-looking information" under applicable Canadian securities legislation (collectively, "forward-looking statements"). Forward-looking statements include statements that may relate to our plans, objectives, goals, strategies, future events, future revenue or performance, capital expenditures, financing needs and other information that may not be based on historical fact. Forward-looking statements can often be identified by the use of terminology such as "believe", "may", "plan", "will", "estimate", "continue", "anticipate", "intend", "expect", "look forward to" and similar expressions. Forward-looking statements are necessarily based on estimates and assumptions made by us based on our experience and perception of historical trends, current conditions and expected future developments, as well as other factors we believe are appropriate.

By their very nature, forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. A detailed discussion of the risks and uncertainties facing Correvio are discussed in the annual report and detailed from time to time in our other filings with the Securities and Exchange Commission ("SEC") available at www.sec.gov and the Canadian securities regulatory authorities at www.sedar.com. In particular, we direct your attention to Correvio's Annual Report on Form 40-F for the year ended December 31, 2018. All of the risks and certainties disclosed in those filings are hereby incorporated by reference in their entirety into this news release.

While Correvio makes these forward-looking statements in good faith, given these risks, uncertainties and factors, you are cautioned not to place undue reliance on any forward-looking statements made in this press release. All forward-looking statements made herein are based on our current expectations and we undertake no obligation to revise or update such forward-looking statements to reflect subsequent events or circumstances, except as required by law. Investors are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to their inherent uncertainty.

Correvio® and the Correvio Logo are the proprietary trademarks of Correvio Pharma Corp.
Aggrastat® and Brinavess® are trademarks owned by Correvio and its affiliates worldwide.
Xydalba™ is a trademark of Allergan Pharmaceuticals International Limited, and used under license.
Zevtera® and Mabelio® are trademarks owned by Basilea Pharmaceutica Ltd. and its affiliates, and used under license.
Esmocard® and Esmocard Lyo® are trademarks owned by Orpha-Devel Handels und Vertriebs GmbH, and used under license.
Trevyent® is a trademark of SteadyMed Ltd. and used under license.
All other trademarks are the property of their respective owners.

View original content:http://www.prnewswire.com/news-releases/correvio-announces-zevtera-abstracts-at-eccmid-2019-300823890.html

SOURCE Correvio Pharma Corp

 

View original content: http://www.newswire.ca/en/releases/archive/April2019/03/c0427.html

%CIK: 0001036141

For further information: Justin Renz, President & CFO, Correvio Pharma Corp., 604.677.6905 ext. 128, 800.330.9928, jrenz@correvio.com; Argot Partners, Michelle Carroll/Claudia Styslinger, 212.600.1902, michelle@argotpartners.com, claudia@argotpartners.com

CO: Correvio Pharma Corp

CNW 09:29e 03-APR-19

 EX-99.1 3 ex991.pdf PRINTER-FRIENDLY VERSION begin 644 ex991.pdf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�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�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